About
Alzheimer's Diagnostic & Vaccine
Areas of Focus
Categories
DiagnosticsVaccine
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
158
By Phase
PHASE2: 1PHASE1: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT03461276Lead Sponsor
Safety and Immunogenicity of Repeated Doses of ABvac40 in Patients With a-MCI or Vm-AD
PHASE2Completed
134 participants
Started: Dec 13, 2017 · Completed: Mar 23, 2023
NCT03113812Lead Sponsor
Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients
PHASE1Completed
24 participants
Started: Jan 1, 2014 · Completed: Jul 30, 2015
Locations (1)
Headquarters
Zaragoza, Spain
Map
Loading map...